What Type Of Atrioventricular Block Describes This Rhythm

This rhythm demonstratesa second-degree atrioventricular (AV) block, Mobitz type II. Understanding this specific classification requires examining the electrical conduction pathway between the atria and ventricles, the heart's natural pacemaker system, and the precise abnormalities visible on an ECG.

Introduction

The heart's rhythm is orchestrated by an intricate electrical conduction system. This system ensures the atria contract before the ventricles, allowing efficient blood flow. A critical junction in this pathway is the atrioventricular (AV) node, located between the atria and ventricles. The AV node acts as a gatekeeper, delaying the electrical signal to allow atrial contraction to complete before ventricular contraction begins. Normally, this delay results in a consistent PR interval on an ECG. When this conduction is disrupted, it manifests as an AV block. This article delves into the specific characteristics of second-degree AV block, Mobitz type II, explaining its identification, underlying mechanisms, clinical significance, and management.

What is Second-Degree AV Block, Mobitz Type II?

Second-degree AV block (Mobitz II) represents a significant interruption in the normal conduction of electrical impulses from the atria to the ventricles. Unlike first-degree block, which simply delays conduction, second-degree block involves intermittent failure of the AV node to conduct a certain percentage of impulses. The hallmark of Mobitz II is that the blocked beats occur in a regular sequence, typically every other beat or every third beat. This regularity is a crucial distinguishing feature from first-degree block (where PR prolongation occurs but every impulse is conducted) and from Mobitz type I (Wenckebach), where the PR interval progressively lengthens until a beat is dropped, followed by a shorter PR interval.

Identifying Mobitz Type II on ECG

Recognizing Mobitz II block on an electrocardiogram (ECG) relies on specific patterns:

1. Regular Rhythm: The underlying rhythm is often regular, meaning the time between consecutive ventricular complexes (QRS complexes) is consistent, except for the dropped beats.
2. Dropped QRS Complexes: Periodically, a QRS complex fails to appear after a P wave. This is the defining feature of second-degree block.
3. Consistent PR Interval Before Drop: Before each dropped beat, the PR interval is consistently long and normal (or slightly prolonged, but not progressively longer). This means the AV node is capable of conducting the impulse when it does conduct, but it fails to do so at regular intervals.
4. Normal QRS Duration: The QRS complex duration is typically normal (less than 120 ms in adults), indicating that the ventricular myocardium itself is functioning normally. The problem lies upstream, in the conduction system between the atria and ventricles.
5. No Retrograde P Waves: P waves preceding the dropped QRS are usually upright and precede the QRS by a normal PR interval. There is no evidence of retrograde conduction (P waves appearing after the QRS, indicating ventricular activation before atrial activation).

Example Pattern: A rhythm strip might show a sequence like: P - P - P - QRS - P - P - P - QRS - P - P - P - QRS (dropped beat) - P - P - P - QRS - ... The PR interval is long before each QRS that appears, and a QRS is missing after the third P wave in the sequence.

Scientific Explanation: The Pathophysiology of Mobitz II

The precise mechanism underlying Mobitz II block involves dysfunction within the distal conduction system, primarily the bundle branches (bundle of His, bundle branches, and fascicles). Here's a breakdown:

1. Normal Conduction Pathway: The electrical impulse originates in the sinoatrial (SA) node, travels through the atria (causing P waves), then reaches the AV node. The AV node delays the impulse, allowing atrial systole to complete. The impulse then rapidly travels down the bundle of His, through the bundle branches, and finally through the Purkinje fibers to activate the ventricles (causing QRS complexes).
2. The Mobitz II Defect: In Mobitz II, the electrical impulse encounters a focal area of structural or functional abnormality within one of the bundle branches (often the left bundle branch). This abnormality acts as a weak point.
3. Failure of Conduction: When the impulse encounters this weak point, it may fail to penetrate and continue down the normal pathway. This results in the blocking of that specific impulse.
4. Regular Failure: The location of the defect is fixed. Therefore, the impulse fails to conduct through that specific pathway with a predictable, regular frequency. It's as if the bundle branch is "kinking" at a specific point, causing the impulse to stall and fail to propagate down that branch at regular intervals. This is why the dropped beats occur at regular intervals (e.g., every other beat).
5. Normal Conduction Elsewhere: Since the SA node, AV node, and the other bundle branch are functioning normally, the impulses that do successfully traverse the defective branch (or the other branch) produce normal QRS complexes. The ventricles are activated normally when conduction occurs.

This mechanism distinguishes Mobitz II from Wenckebach (Mobitz I), where the entire conduction system (specifically the AV node) is progressively slowing down, causing the PR interval to lengthen progressively until a beat is dropped, followed by a reset with a shorter PR interval.

Clinical Implications and Management

Mobitz II block carries significant clinical implications:

1. Risk of Complete Heart Block: A major concern is that Mobitz II can progress to third-degree (complete) AV block, where no impulses from the atria reach the ventricles. This is a medical emergency requiring immediate pacemaker implantation.
2. Symptomatic vs. Asymptomatic: Mobitz II can be asymptomatic or cause symptoms like dizziness, lightheadedness, fainting (syncope), fatigue, or exercise intolerance due to reduced cardiac output during the blocked beats.
3. Underlying Cause: Identifying and treating the underlying cause is paramount. Common causes include:
   • Ischemic heart disease (coronary artery disease)
   • Infiltrative diseases (e.g., sarcoidosis, amyloidosis)
   • Inflammatory conditions (e.g., lupus, Lyme disease)
   • Cardiomyopathies
   • Post-cardiac surgery
   • Certain medications (e.g., beta-blockers, calcium channel blockers, digoxin - though less common now)
4. Management Strategies:
   • Pacemaker Implantation: This is the definitive treatment for symptomatic Mobitz II block

Continuing from the provided text, the clinical management of Mobitz II block extends beyond initial pacemaker implantation:

Post-Implantation Management and Prognosis:

1. Pacemaker Programming and Follow-up: After implantation, the pacemaker's settings (rate, mode, sensing thresholds) must be carefully programmed to ensure adequate ventricular pacing during blocked intervals while minimizing unnecessary pacing. Regular follow-up appointments are essential to monitor pacemaker function (checking battery life, lead integrity, and capture), assess for any signs of complications, and adjust settings as needed based on the patient's evolving condition and exercise tolerance. Patients are educated on recognizing signs of pacemaker malfunction or infection.
2. Addressing Underlying Causes: As emphasized, identifying and treating the root cause is crucial. This may involve optimizing medical therapy for ischemic heart disease (e.g., revascularization, statins), managing infiltrative or inflammatory conditions (e.g., steroids for sarcoidosis or Lyme disease), treating cardiomyopathies, or carefully reviewing medications (though beta-blockers, calcium channel blockers, and digoxin are less commonly implicated in Mobitz II than in Wenckebach).
3. Symptom Monitoring and Lifestyle: Patients with Mobitz II require ongoing monitoring for symptoms like syncope, presyncope, dizziness, or fatigue. While a pacemaker alleviates the mechanical conduction problem, patients should be advised on lifestyle modifications that may help optimize cardiac function, such as managing fluid intake (if applicable), avoiding excessive alcohol, and engaging in appropriate exercise programs under medical guidance. Regular cardiac check-ups remain vital.
4. Prognosis: The prognosis for Mobitz II block is heavily dependent on the underlying etiology and the success of treatment. When caused by reversible factors (e.g., acute ischemia, medication effect), recovery of conduction is possible, though often partial. In cases of irreversible structural damage (e.g., extensive myocardial fibrosis from prior infarction, infiltrative disease), the block is likely permanent, necessitating lifelong pacing. The primary risk remains progression to complete heart block (third-degree AV block), which is a medical emergency. Early diagnosis and intervention significantly improve outcomes, preventing catastrophic events like asystole or sudden cardiac death.

Conclusion:

Mobitz II second-degree AV block represents a critical conduction disorder characterized by intermittent failure of impulses to traverse a specific bundle branch defect, leading to predictable dropped beats. Unlike the progressive delay seen in Wenckebach (Mobitz I), Mobitz II involves a fixed conduction gap. Its clinical significance lies in the substantial risk of progression to life-threatening complete heart block, demanding prompt recognition and intervention. While pacemaker implantation is the definitive treatment for symptomatic cases, management must also address the underlying cause and involve meticulous post-implantation care, including programming optimization, regular follow-up, and patient education. Understanding the distinct mechanisms and implications of Mobitz II versus other AV blocks is paramount for clinicians to ensure timely and appropriate management, ultimately safeguarding patient survival and quality of life.